P
Peter Bauer
Researcher at University of Tübingen
Publications - 34
Citations - 1797
Peter Bauer is an academic researcher from University of Tübingen. The author has contributed to research in topics: Ataxia & Spinocerebellar ataxia. The author has an hindex of 18, co-authored 29 publications receiving 1524 citations. Previous affiliations of Peter Bauer include Winterthur Museum, Garden and Library & University of Vienna.
Papers
More filters
Journal ArticleDOI
A Revised Timescale for Human Evolution Based on Ancient Mitochondrial Genomes
Qiaomei Fu,Qiaomei Fu,Alissa Mittnik,Philip L. F. Johnson,Kirsten I. Bos,Kirsten I. Bos,Martina Lari,Ruth Bollongino,Chengkai Sun,Liane Giemsch,Ralf Schmitz,Joachim Burger,Annamaria Ronchitelli,Fabio Martini,Renata Grifoni Cremonesi,Jiří Svoboda,Jiří Svoboda,Peter Bauer,David Caramelli,Sergi Castellano,David Reich,David Reich,Svante Pääbo,Johannes Krause +23 more
TL;DR: This work uses mitochondrial genome sequences from ten securely dated ancient modern humans spanning 40,000 years as calibration points for the mitochondrial clock, thus yielding a direct estimate of the mitochondrial substitution rate and implies a separation of non-Africans from the most closely related sub-Saharan African mitochondrial DNAs that occurred less than 62-95 kya.
Journal ArticleDOI
Impact of minimal increases in serum creatinine on outcome in patients after cardiothoracic surgery: do we have to revise current definitions of acute renal failure?
Andrea Lassnigg,Edith R. Schmid,Michael Hiesmayr,Christian Falk,Wilfred Druml,Peter Bauer,Daniel Schmidlin +6 more
TL;DR: Measuring repeat serum creatinine concentrations within 48 hrs and determining &Dgr;Crea were the most effective discrimination method to find patients at risk for adverse postoperative outcome after cardiac surgery, better than application of this sole criterion to the RIFLE (least discriminatory) or the AKIN classification.
Journal ArticleDOI
Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data
Heike Jacobi,Kathrin Reetz,Kathrin Reetz,Sophie Tezenas du Montcel,Peter Bauer,Caterina Mariotti,Lorenzo Nanetti,Maria Rakowicz,Anna Sulek,Alexandra Durr,Perrine Charles,Alessandro Filla,Antonella Antenora,Ludger Schöls,Julia Schicks,Jon Infante,Jun Suk Kang,Dagmar Timmann,Roberto Di Fabio,Marcella Masciullo,Laszlo Baliko,Béla Melegh,Sylvia Boesch,Katrin Bürk,Annkathrin Peltz,Jörg B. Schulz,Isabelle Dufaure-Garé,Thomas Klockgether,Thomas Klockgether +28 more
TL;DR: Preclinical SCA1 and SCA2 mutation carriers seem to have mild coordination deficits and abnormalities in the brain that are more common in carriers who are closer to the estimated onset of ataxia.
Journal ArticleDOI
Autosomal recessive spastic ataxia of Charlevoix Saguenay (ARSACS): expanding the genetic, clinical and imaging spectrum
Matthis Synofzik,Anne S. Soehn,Janina Gburek-Augustat,Julia Schicks,Kathrin N. Karle,Rebecca Schüle,Tobias B. Haack,Martin Schöning,Saskia Biskup,Sabine Rudnik-Schöneborn,Jan Senderek,Jan Senderek,Karl-Titus Hoffmann,Patrick MacLeod,Johannes Schwarz,Benjamin Bender,Stefan Krüger,Friedmar Kreuz,Peter Bauer,Ludger Schöls +19 more
TL;DR: It is demonstrated that each feature of the classical ARSACS triad might be missing in ARSacS, and characteristic MRI features – which also extend to supratentorial regions and involve the cerebral cortex – will help to establish the diagnosis in most cases.
Journal ArticleDOI
Diagnostic tests for Niemann-Pick disease type C (NP-C): A critical review.
Marie T. Vanier,Paul Gissen,Paul Gissen,Peter Bauer,Maria Josep Coll,Alberto Burlina,Christian J. Hendriksz,Christian J. Hendriksz,Philippe Latour,Cyril Goizet,Richard W. D. Welford,Thorsten Marquardt,Stefan A. Kolb +12 more
TL;DR: Advances in mass spectrometry has allowed identification of several sensitive plasma biomarkers elevated in NP-C, which, together with the concomitant progress in molecular genetic technology, have greatly impacted the strategy of laboratory testing.